{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:46:38Z","timestamp":1740138398961,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,18]],"date-time":"2017-12-18T00:00:00Z","timestamp":1513555200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81100560"],"award-info":[{"award-number":["81100560"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s12020-017-1481-4","type":"journal-article","created":{"date-parts":[[2017,12,18]],"date-time":"2017-12-18T08:33:52Z","timestamp":1513586032000},"page":"218-225","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Decreased miR-17-92 cluster expression level in serum and granulocytes preceding onset of antithyroid drug-induced agranulocytosis"],"prefix":"10.1007","volume":"59","author":[{"given":"Jing","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuncheng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaoyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinhua","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gebo","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,18]]},"reference":[{"key":"1481_CR1","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra042972","volume":"352","author":"DS Cooper","year":"2005","unstructured":"D.S. Cooper, Antithyroid drugs. N. Engl. J. Med. 352, 905\u2013917 (2005)","journal-title":"N. Engl. J. Med."},{"key":"1481_CR2","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1210\/jc.2013-2569","volume":"98","author":"H Nakamura","year":"2013","unstructured":"H. Nakamura, A. Miyauchi, N. Miyawaki, J. Imagawa, Analysis of 754 cases of antithyroid drug-induced agranulocytosis over 30 years in Japan. J. Clin. Endocrinol. Metab. 98, 4776\u20134783 (2013)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1481_CR3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1089\/105072504323150787","volume":"14","author":"J Tajiri","year":"2004","unstructured":"J. Tajiri, S. Noguchi, Antithyroid drug-induced agranulocytosis: special reference to normal white blood cell count agranulocytosis. Thyroid 14, 459\u2013462 (2004)","journal-title":"Thyroid"},{"key":"1481_CR4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1517\/17425255.2015.985649","volume":"11","author":"A Johnston","year":"2015","unstructured":"A. Johnston, J. Uetrecht, Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis. Expert. Opin. Drug. Metab. Toxicol. 11, 243\u2013257 (2015)","journal-title":"Expert. Opin. Drug. Metab. Toxicol."},{"key":"1481_CR5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1507\/endocrj.EJ12-0332","volume":"60","author":"J Yang","year":"2013","unstructured":"J. Yang, J. Zhong, X.H. Xiao, L.Z. Zhou, Y.J. Chen, J.H. Liu, R.X. Cao, G.B. Wen, The relationship between bone marrow characteristics and the clinical prognosis of antithyroid drug-induced agranulocytosis. Endocr. J. 60, 185\u2013189 (2013)","journal-title":"Endocr. J."},{"key":"1481_CR6","doi-asserted-by":"publisher","unstructured":"T.S. Plantinga, P. Arts, G.H. Knarren, A.H. Mulder, I.M. Wakelkamp, A.R. Hermus, L.A. Joosten, M.G. Netea, P.H. Bisschop, W.W. De Herder, H.J. Beijers, I.J. De Bruin, C. Gilissen, J.A. Veltman, A. Hoischen, J.W. Smit, R.T. Netea-Maier, Rare NOX3 variants confer susceptibility to agranulocytosis during thyrostatic treatment of Graves\u2019 disease. Clin. Pharmacol. Thera (2017). https:\/\/doi.org\/10.1002\/cpt.733","DOI":"10.1002\/cpt.733"},{"key":"1481_CR7","volume":"6","author":"PL Chen","year":"2015","unstructured":"P.L. Chen, S.R. Shih, P.W. Wang, Y.C. Lin, C.C. Chu, J.H. Lin, S.C. Chen, C.C. Chang, T.S. Huang, K.S. Tsai, F.Y. Tseng, C.Y. Wang, J.Y. Lu, W.Y. Chiu, C.C. Chang, Y.H. Chen, Y.T. Chen, C.S. Fann, W.S. Yang, T.C. Chang, Genetic determinants of antithyroid drug-induced agranulocytosis by human leukocyte antigen genotyping and genome-wide association study. Nat. Commun. 6, 7633 (2015)","journal-title":"Nat. Commun."},{"key":"1481_CR8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S2213-8587(16)00113-3","volume":"4","author":"P Hallberg","year":"2016","unstructured":"P. Hallberg, N. Eriksson, L. Ibanez, E. Bondon-Guitton, R. Kreutz, A. Carvajal, M.I. Lucena, E.S. Ponce, M. Molokhia, J. Martin, T. Axelsson, Q.Y. Yue, P.K. Magnusson, M. Wadelius, D.a.C.C. Eu, Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European population. Lancet Diabetes Endocrinol. 4, 507\u2013516 (2016)","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1481_CR9","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","volume":"431","author":"V Ambros","year":"2004","unstructured":"V. Ambros, The functions of animal microRNAs. Nature 431, 350\u2013355 (2004)","journal-title":"Nature"},{"key":"1481_CR10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-981-10-4310-9_8","volume":"983","author":"Q Zou","year":"2017","unstructured":"Q. Zou, Y. Liang, H. Luo, W. Yu, miRNA-mediated RNAa by targeting enhancers. Adv. Exp. Med. Biol. 983, 113\u2013125 (2017)","journal-title":"Adv. Exp. Med. Biol."},{"key":"1481_CR11","first-page":"285","volume":"5","author":"H Liang","year":"2014","unstructured":"H. Liang, F. Gong, S. Zhang, C.Y. Zhang, K. Zen, X. Chen, The origin, function, and diagnostic potential of extracellular microRNAs in human body fluids. Wiley interdisciplinary reviews. RNA 5, 285\u2013300 (2014)","journal-title":"RNA"},{"key":"1481_CR12","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1517\/14712590902932889","volume":"9","author":"MA Cortez","year":"2009","unstructured":"M.A. Cortez, G.A. Calin, MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert. Opin. Biol. Ther. 9, 703\u2013711 (2009)","journal-title":"Expert. Opin. Biol. Ther."},{"key":"1481_CR13","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1007\/s00204-016-1828-2","volume":"90","author":"V Ghai","year":"2016","unstructured":"V. Ghai, K. Wang, Recent progress toward the use of circulating microRNAs as clinical biomarkers. Arch. Toxicol. 90, 2959\u20132978 (2016)","journal-title":"Arch. Toxicol."},{"key":"1481_CR14","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nature03552","volume":"435","author":"L He","year":"2005","unstructured":"L. He, J.M. Thomson, M.T. Hemann, E. Hernando-Monge, D. Mu, S. Goodson, S. Powers, C. Cordon-Cardo, S.W. Lowe, G.J. Hannon, S.M. Hammond, A microRNA polycistron as a potential human oncogene. Nature 435, 828\u2013833 (2005)","journal-title":"Nature"},{"key":"1481_CR15","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/cdd.2013.125","volume":"20","author":"E Mogilyansky","year":"2013","unstructured":"E. Mogilyansky, I. Rigoutsos, The miR-17\/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease. Cell. Death Differ. 20, 1603\u20131614 (2013)","journal-title":"Cell. Death Differ."},{"key":"1481_CR16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1152\/japplphysiol.01291.2009","volume":"109","author":"S Radom-Aizik","year":"2010","unstructured":"S. Radom-Aizik, F. Zaldivar Jr., S. Oliver, P. Galassetti, D.M. Cooper, Evidence for microRNA involvement in exercise-associated neutrophil gene expression changes. J. Appl. Physiol. 109, 252\u2013261 (2010)","journal-title":"J. Appl. Physiol."},{"key":"1481_CR17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature03076","volume":"432","author":"MN Poy","year":"2004","unstructured":"M.N. Poy, L. Eliasson, J. Krutzfeldt, S. Kuwajima, X. Ma, P.E. Macdonald, S. Pfeffer, T. Tuschl, N. Rajewsky, P. Rorsman, M. Stoffel, A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432, 226\u2013230 (2004)","journal-title":"Nature"},{"key":"1481_CR18","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1158\/0008-5472.CAN-03-3773","volume":"64","author":"A Ota","year":"2004","unstructured":"A. Ota, H. Tagawa, S. Karnan, S. Tsuzuki, A. Karpas, S. Kira, Y. Yoshida, M. Seto, Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res. 64, 3087\u20133095 (2004)","journal-title":"Cancer Res."},{"key":"1481_CR19","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1073\/pnas.0914900107","volume":"107","author":"S Mi","year":"2010","unstructured":"S. Mi, Z. Li, P. Chen, C. He, D. Cao, A. Elkahloun, J. Lu, L.A. Pelloso, M. Wunderlich, H. Huang, R.T. Luo, M. Sun, M. He, M.B. Neilly, N.J. Zeleznik-Le, M.J. Thirman, J.C. Mulloy, P.P. Liu, J.D. Rowley, J. Chen, Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia. Proc. Natl. Acad. Sci. USA 107, 3710\u20133715 (2010)","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1481_CR20","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1182\/blood-2006-09-045104","volume":"109","author":"L Venturini","year":"2007","unstructured":"L. Venturini, K. Battmer, M. Castoldi, B. Schultheis, A. Hochhaus, M.U. Muckenthaler, A. Ganser, M. Eder, M. Scherr, Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. Blood 109, 4399\u20134405 (2007)","journal-title":"Blood"},{"key":"1481_CR21","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/PPO.0b013e318258b60a","volume":"18","author":"CP Concepcion","year":"2012","unstructured":"C.P. Concepcion, C. Bonetti, A. Ventura, The microRNA-17-92 family of microRNA clusters in development and disease. Cancer J. 18, 262\u2013267 (2012)","journal-title":"Cancer J."},{"key":"1481_CR22","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.ajpath.2011.06.008","volume":"179","author":"M Ji","year":"2011","unstructured":"M. Ji, E. Rao, H. Ramachandrareddy, Y. Shen, C. Jiang, J. Chen, Y. Hu, A. Rizzino, W.C. Chan, K. Fu, T.W. Mckeithan, The miR-17-92 microRNA cluster is regulated by multiple mechanisms in B-cell malignancies. Am. J. Pathol. 179, 1645\u20131656 (2011)","journal-title":"Am. J. Pathol."},{"key":"1481_CR23","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.cell.2008.02.019","volume":"132","author":"A Ventura","year":"2008","unstructured":"A. Ventura, A.G. Young, M.M. Winslow, L. Lintault, A. Meissner, S.J. Erkeland, J. Newman, R.T. Bronson, D. Crowley, J.R. Stone, R. Jaenisch, P.A. Sharp, T. Jacks, Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132, 875\u2013886 (2008)","journal-title":"Cell"},{"key":"1481_CR24","doi-asserted-by":"crossref","first-page":"26926","DOI":"10.18632\/oncotarget.8731","volume":"7","author":"Y Li","year":"2016","unstructured":"Y. Li, A. Deutzmann, P.S. Choi, A.C. Fan, D.W. Felsher, BIM mediates oncogene inactivation-induced apoptosis in multiple transgenic mouse models of acute lymphoblastic leukemia. Oncotarget 7, 26926\u201326934 (2016)","journal-title":"Oncotarget"},{"key":"1481_CR25","doi-asserted-by":"crossref","first-page":"8547","DOI":"10.1158\/0008-5472.CAN-10-1938","volume":"70","author":"L Hong","year":"2010","unstructured":"L. Hong, M. Lai, M. Chen, C. Xie, R. Liao, Y.J. Kang, C. Xiao, W.Y. Hu, J. Han, P. Sun, The miR-17-92 cluster of microRNAs confers tumorigenicity by inhibiting oncogene-induced senescence. Cancer Res. 70, 8547\u20138557 (2010)","journal-title":"Cancer Res."},{"key":"1481_CR26","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1080\/10428194.2016.1213827","volume":"58","author":"X Zhang","year":"2017","unstructured":"X. Zhang, Y. Chen, P. Zhao, L. Zang, Z. Zhang, X. Wang, MicroRNA-19a functions as an oncogene by regulating PTEN\/AKT\/pAKT pathway in myeloma. Leuk. Lymphoma 58, 932\u2013940 (2017)","journal-title":"Leuk. Lymphoma"},{"key":"1481_CR27","doi-asserted-by":"crossref","first-page":"19381","DOI":"10.18632\/oncotarget.4574","volume":"6","author":"M Dal","year":"2015","unstructured":"M. Dal Bo, R. Bomben, L. Hernandez, V. Gattei, The MYC\/miR-17-92 axis in lymphoproliferative disorders: a common pathway with therapeutic potential. Oncotarget 6, 19381\u201319392 (2015)","journal-title":"Oncotarget"},{"key":"1481_CR28","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1080\/15384101.2016.1215386","volume":"15","author":"G Zhang","year":"2016","unstructured":"G. Zhang, X. Liu, W. Wang, Y. Cai, S. Li, Q. Chen, M. Liao, M. Zhang, G. Zeng, B. Zhou, C.G. Feng, X. Chen, Down-regulation of miR-20a-5p triggers cell apoptosis to facilitate mycobacterial clearance through targeting JNK2 in human macrophages. Cell. Cycle 15, 2527\u20132538 (2016)","journal-title":"Cell. Cycle"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-017-1481-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-017-1481-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-017-1481-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T12:21:22Z","timestamp":1603542082000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-017-1481-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,18]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["1481"],"URL":"https:\/\/doi.org\/10.1007\/s12020-017-1481-4","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"type":"print","value":"1355-008X"},{"type":"electronic","value":"1559-0100"}],"subject":[],"published":{"date-parts":[[2017,12,18]]}}}